We are live on
!
Find out more
OAM
Oberweis Asset Management Portfolio holdings
AUM
$3.39B
1-Year Est. Return
105.5%
This Fund
S&P 500
This Quarter
Est. Return
+8.75%
1 Year Est. Return
+105.5%
3 Year Est. Return
+311.52%
5 Year Est. Return
+632.9%
10 Year Est. Return
+11,604.3%
AUM
$550M
AUM Growth
+$52.4M
(+11%)
Cap. Flow
+$19.4M
Cap. Flow
% of AUM
3.53%
Top 10 Holdings %
Top 10 Hldgs %
52.39%
Holding
230
New
29
Increased
85
Reduced
59
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$47.5M |
| 2 |
uniQure
QURE
|
+$28.2M |
| 3 |
CACI
CACI
|
+$6.46M |
| 4 |
IPHI
INPHI CORPORATION
IPHI
|
+$4.67M |
| 5 |
ALTR
Altair Engineering Inc
ALTR
|
+$4.62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$33.8M |
| 2 |
GOOS
Canada Goose Holdings
GOOS
|
+$13.2M |
| 3 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$8.78M |
| 4 |
CYBR
CyberArk
CYBR
|
+$5.02M |
| 5 |
Ligand Pharmaceuticals
LGND
|
+$4.83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 39.64% |
| 2 | Consumer Staples | 13.57% |
| 3 | Technology | 13.22% |
| 4 | Industrials | 12.46% |
| 5 | Consumer Discretionary | 9.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
CNO Financial Group
CNO
$5.14B
| $744K | 0.14% |
44,630
+5,600
| +14% | +$92.6K |
|
102
Associated Banc-Corp
ASB
$5.83B
| $739K | 0.13% |
34,940
-14,600
| -29% | -$317K |
|
103
Enterprise Financial Services Corp
EFSC
$2.4B
| $736K | 0.13% |
17,700
+500
| +3% | +$20.9K |
|
104
TechTarget
TTGT
$325M
| $712K | 0.13% |
+33,500
| New | +$626K |
|
105
Cousins Properties
CUZ
$5.19B
| $707K | 0.13% |
19,542
| – | – |
|
106
Herc Holdings
HRI
$5.02B
| $706K | 0.13% |
15,400
-19,500
| -56% | -$812K |
|
107
Simmons First National
SFNC
$3.41B
| $687K | 0.12% |
29,530
-9,700
| -25% | -$236K |
|
108
Matsons
MATX
$6.13B
| $676K | 0.12% |
17,410
-900
| -5% | -$34K |
|
109
National Healthcare
NHC
$3.53B
| $674K | 0.12% |
+8,300
| New | +$641K |
|
110
Radian Group
RDN
$5.18B
| $673K | 0.12% |
29,460
+800
| +3% | +$18.2K |
|
111
Artivion
AORT
$1.3B
| $672K | 0.12% |
22,444
-15,900
| -41% | -$472K |
|
112
MasTec
MTZ
$21.1B
| $672K | 0.12% |
13,040
-1,100
| -8% | -$54.3K |
|
|
TOWR
113
DELISTED
Tower International, Inc.
TOWR
| $667K | 0.12% |
34,180
-2,000
| -6% | -$41.5K |
|
114
Graphic Packaging
GPK
$3.17B
| $665K | 0.12% |
47,600
+26,600
| +127% | +$357K |
|
115
Digital Turbine
APPS
$975M
| $650K | 0.12% |
+130,000
| New | +$523K |
|
|
IOTS
116
DELISTED
Adesto Technologies Corp
IOTS
| $641K | 0.12% |
+78,600
| New | +$564K |
|
117
Heritage Insurance Holdings
HRTG
$889M
| $640K | 0.12% |
41,513
+1,200
| +3% | +$17.7K |
|
118
Vishay Intertechnology
VSH
$5.25B
| $635K | 0.12% |
38,450
-2,600
| -6% | -$45.9K |
|
119
Dana Inc
DAN
$2.9B
| $634K | 0.12% |
31,780
+3,600
| +13% | +$64.1K |
|
120
Digi International
DGII
$2.63B
| $633K | 0.12% |
49,900
-14,100
| -22% | -$171K |
|
121
Pediatrix Medical
MD
$2.18B
| $627K | 0.11% |
24,865
+8,400
| +51% | +$226K |
|
122
Pinduoduo
PDD
$126B
| $619K | 0.11% |
+30,000
| New | +$650K |
|
123
Eagle Bancorp
EGBN
$846M
| $606K | 0.11% |
11,200
+500
| +5% | +$27.3K |
|
|
PYX
124
DELISTED
Pyxus International, Inc.
PYX
| $600K | 0.11% |
39,500
-5,200
| -12% | -$98K |
|
125
OptimizeRx
OPRX
$114M
| $599K | 0.11% |
+37,000
| New | +$500K |
|
Similar funds
BG
DFO
VFCM
MCM
EFM
DIA
5NCM
QCG
Oberweis Asset Management's Q2 2019 Portfolio in Review
As of Q2 2019, Oberweis Asset Management held 230 positions worth $550M, up 11% from $498M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Oberweis Asset Management deployed $19.4M of net new capital in Q2 2019, opening 29 new positions and adding to 85 existing holdings. Its largest new stake was uniQure: 442,900 shares worth $34.6M.
By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 28% a quarter earlier, followed by Consumer Staples and Technology.
On the sell side, the largest reduction was Ligand Pharmaceuticals, an estimated $4.83M trimmed.
- Oberweis Asset Management's largest Q2 2019 buy was uniQure: 442,900 shares worth $34.6M.
- Oberweis Asset Management added most to GW Pharmaceuticals Plc American Depositary Shares in Q2 2019, an estimated $47.5M increase.
- Oberweis Asset Management's biggest Q2 2019 reduction was Ligand Pharmaceuticals, cutting an estimated $4.83M.
- Oberweis Asset Management fully exited Mellanox Technologies, Ltd. in Q2 2019, selling an estimated $33.8M.
- Oberweis Asset Management's ten largest holdings make up 52% of its $550M portfolio in Q2 2019.
- Oberweis Asset Management opened 29 new positions and closed 34 in Q2 2019.
- Oberweis Asset Management's portfolio value rose 11% quarter-over-quarter to $550M.
Based on Oberweis Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.